Equifax (EFX) to Release Quarterly Earnings on Wednesday

Equifax (NYSE:EFX - Get Free Report) will likely be announcing its Q2 2025 earnings results before the market opens on Wednesday, July 16th. Analysts expect the company to announce earnings of $1.91 per share and revenue of $1.51 billion for the quarter. Equifax has set its FY 2025 guidance at 7.250-7.650 EPS and its Q2 2025 guidance at 1.850-1.950 EPS.

Equifax (NYSE:EFX - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The credit services provider reported $1.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.08. Equifax had a return on equity of 18.81% and a net margin of 10.68%. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.41 billion. On average, analysts expect Equifax to post $8 EPS for the current fiscal year and $10 EPS for the next fiscal year.

Equifax Stock Performance

NYSE:EFX opened at $264.20 on Wednesday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.85 and a current ratio of 0.85. Equifax has a 52-week low of $199.98 and a 52-week high of $309.63. The firm has a market cap of $32.81 billion, a price-to-earnings ratio of 54.03, a PEG ratio of 2.87 and a beta of 1.60. The business's fifty day moving average is $264.58 and its 200 day moving average is $252.98.

Equifax Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.76%. This is a positive change from Equifax's previous quarterly dividend of $0.39. The ex-dividend date of this dividend was Friday, May 23rd. Equifax's payout ratio is presently 40.90%.

Insider Transactions at Equifax

In related news, CEO Mark W. Begor sold 22,160 shares of the stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $256.61, for a total transaction of $5,686,477.60. Following the completion of the sale, the chief executive officer directly owned 142,395 shares in the company, valued at $36,539,980.95. This represents a 13.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP John W. Gamble, Jr. sold 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $259.10, for a total value of $518,200.00. Following the transaction, the executive vice president directly owned 65,176 shares of the company's stock, valued at $16,887,101.60. The trade was a 2.98% decrease in their position. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EFX. Brighton Jones LLC boosted its stake in Equifax by 49.2% during the 4th quarter. Brighton Jones LLC now owns 3,638 shares of the credit services provider's stock valued at $927,000 after purchasing an additional 1,200 shares during the last quarter. Great Lakes Advisors LLC bought a new stake in Equifax during the first quarter worth approximately $204,000. Finally, Empowered Funds LLC grew its stake in shares of Equifax by 14.6% during the first quarter. Empowered Funds LLC now owns 2,523 shares of the credit services provider's stock valued at $615,000 after buying an additional 321 shares during the last quarter. Institutional investors own 96.20% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Barclays reiterated an "equal weight" rating and set a $260.00 price objective (down from $325.00) on shares of Equifax in a research note on Friday, April 4th. Wells Fargo & Company upped their target price on Equifax from $306.00 to $310.00 and gave the stock an "overweight" rating in a research note on Monday. Royal Bank Of Canada restated an "outperform" rating and issued a $300.00 target price on shares of Equifax in a research note on Wednesday, June 18th. Morgan Stanley restated an "overweight" rating and issued a $305.00 target price (up from $295.00) on shares of Equifax in a research note on Tuesday, June 10th. Finally, Oppenheimer upped their target price on Equifax from $277.00 to $296.00 and gave the stock an "outperform" rating in a research note on Thursday, May 22nd. Six equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $295.19.

About Equifax

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.